. 2022

Liver spheroids: a robust human in vitro system for testing the therapeutic options of cyclooxygenase 2 in NAFLD/NASH

Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/265816
Digital.CSIC. Repositorio Institucional del CSIC
  • Huete, Javier
  • Fuertes-Agudo, Marina
  • Brea, Rocío
  • Luque-Tévar, María
  • Cucarella, Carme
  • Martín-Sanz, Paloma
  • Casado, Marta
Trabajo presentado en las XV Jornadas CIBER Enfermedades Hepáticas y Digestivas: Jornades científiques del CIBERehd, celebradas en modalidad virtual y de forma presencial en Barcelona (España) del 08 al 09 de noviembre de 2021., Cyclooxygenase (COX) is a key enzyme in the biosynthesis of prostanoids. Prostaglandins are involved in multiple homeostatic processes, as well as playing an important role in the onset of inflammation. COX-2 is an isoform that is expressed and induced by different stimuli in various tissues and cell types; however, in liver, COX-2 expression is restricted to those situations where proliferation and dedifferentiation occur (1). Our previous results have shown that COX-2 expression in hepatocytes protects against hyperglycemia-induced liver damage, peripheral insulin resistance and adiposity in mice fed a high-fat diet (2), and also protects against experimental non-alcoholic steatohepatitis and fibrosis (3)., This work was supported by SAF2016-75004-R and PID2019-108977RB-I00 (MINECO, Spain) and CIBERehd (ISCIII, Spain). M F-A. and M L-T are recipient of FPI fellowship from MINECO (BES-2017-081928 and PRE2020-094885, respectively). We thank FEDER for financial support.
 

DOI: http://hdl.handle.net/10261/265816
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/265816

HANDLE: http://hdl.handle.net/10261/265816
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/265816
 
Ver en: http://hdl.handle.net/10261/265816
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/265816

1106